Ausgabe 3/2016
Inhalt (13 Artikel)
editorial
Rationale of an economically driven PD1 biomarker development in lung cancer—an academic dilemma
Wolfgang Hilbe, Rupert Bartsch, Christoph Zielinski
special report
Novel strategies in the management of chronic lymphocytic leukemia (CLL)
Daniel Heintel
Open Access
short review
Reversal of direct oral anticoagulants in hemophilia treatment
Clemens Feistritzer, Stefan Schmidt
original report
Healthcare resource utilization and G‑CSF use in patients with solid tumors or hematological malignancies hospitalized for febrile neutropenia in Bulgaria, Czech Republic and Slovakia
Georgi Mihaylov, Zhasmina Mihaylova, Lubos Drgona, Andrea Cipkova, Jan Novak, Roumyana Petrova